Delivery Order SPE2DB24D2106-SPE2DB24FAUHG
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,659.73 contract is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract has an ultimate completion date of July 17, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,650.90 contract is for the provision of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure this direct federal award. DMS...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $2,040.63 and covers the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,745.97 by the Defense Logistics Agency (DLA) on September 19, 2025. The delivery order, which carries no set-aside designation, covers the supply of Yuvafem 10 microgram vaginal inserts (18 units) with performance at the company's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 22,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,916.25 firm fixed-price award is for the delivery of YUVAFEM 10 MCG vaginal inserts. The award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC vehicle, under the...
- On September 17, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $2,664.07 to DMS Pharmaceutical Group Inc. for the supply of Yuvafem 10 microgram vaginal inserts (18 units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with performance taking place in Conshohocken, Pennsylvania. The contract carries a firm fixed-price structure with an ultimate completion date of September...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of Yuvafem 10 MCG vaginal inserts, with a total ceiling value of $1,611.60 and an ultimate completion date of July 9, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a range of pharmaceutical products to federal agencies,...
- The Defense Logistics Agency awarded a delivery order valued at $3,125.54 to DMS Pharmaceutical Group Inc. for Yuvafem 10 microgram vaginal inserts (18-unit package), with performance in Conshohocken, Pennsylvania and completion by September 5, 2025. This firm fixed-price delivery order was awarded without a set-aside designation on September 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as the prime...
- This federal contract award, valued at $9,104.55, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The award is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued up to $499,999,999 that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the...
- The federal contract award is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a ceiling value of $1,961.01 and a completion date of April 17, 2024. The contract is not set aside and is part of a larger $499,999,999...
- SPE2DB24D2106Indefinite Delivery Contract
- SPE2DB24D2106-SPE2DB24FAUHGDelivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,906.93, is for the delivery of 4564788297 ! YUVAFEM 10 MCG VAGINAL INSERT 18S, a specialized pharmaceutical product, with a completion date of June 4, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. This contract award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. The company also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, further positioning it as a crucial supplier in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/3/24 |